Catalyst Pharmaceuticals Inc CPRX

NAS: CPRX | ISIN: US14888U1016 30/04/2025

24,29 USD (+0,04%)

(+0,04%) 30/04/2025

Grafiek Catalyst Pharmaceuticals Inc

Grafiek Catalyst Pharmaceuticals Inc

1 dag1d 0,04%
1 week1w 4,74%
1 maand1m 1,55%
3 maanden3m 7,38%
6 maanden6m 10,96%
1 jaar1j 59,80%
5 jaar5j 428,04%

woensdag 7 mei 2025, 22:00

Kwartaalcijfers (1ste kwartaal)

Catalyst Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

13 september 2022 · Catalyst Pharmaceuticals Set to Join S&P SmallCap 600 · Persbericht

15 maart 2021 · Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update · Persbericht

4 maart 2021 · Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021 · Persbericht

22 februari 2021 · Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021 · Persbericht

6 januari 2021 · Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update · Persbericht

Profiel Catalyst Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: catalystpharma.com

Hoofdzetel: Coral Gables, Florida Verenigde Staten

CEO: Patrick McEnany

Werknemers: 71

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe